These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 20857187)

  • 21. Preliminary findings of the effects of rivastigmine, an acetylcholinesterase inhibitor, on working memory in cocaine-dependent volunteers.
    Mahoney JJ; Kalechstein AD; Verrico CD; Arnoudse NM; Shapiro BA; De La Garza R
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Apr; 50():137-42. PubMed ID: 24239594
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Depression and Apathy Among People Living with HIV: Implications for Treatment of HIV Associated Neurocognitive Disorders.
    Bryant VE; Whitehead NE; Burrell LE; Dotson VM; Cook RL; Malloy P; Devlin K; Cohen RA
    AIDS Behav; 2015 Aug; 19(8):1430-7. PubMed ID: 25533921
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Crack-cocaine use accelerates HIV disease progression in a cohort of HIV-positive drug users.
    Baum MK; Rafie C; Lai S; Sales S; Page B; Campa A
    J Acquir Immune Defic Syndr; 2009 Jan; 50(1):93-9. PubMed ID: 19295339
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intra-individual neurocognitive variability confers risk of dependence in activities of daily living among HIV-seropositive individuals without HIV-associated neurocognitive disorders.
    Morgan EE; Woods SP; Grant I;
    Arch Clin Neuropsychol; 2012 May; 27(3):293-303. PubMed ID: 22337933
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of antidepressant treatment on antiretroviral regimen adherence among depressed HIV-infected patients.
    Kumar V; Encinosa W
    Psychiatr Q; 2009 Sep; 80(3):131-41. PubMed ID: 19387832
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessing combinatorial effects of HIV infection and former cocaine dependence on cognitive control processes: A high-density electrical mapping study of response inhibition.
    Wakim KM; Freedman EG; Molloy CJ; Vieyto N; Cao Z; Foxe JJ
    Neuropharmacology; 2021 Sep; 195():108636. PubMed ID: 34090915
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The limited impact that cocaine use patterns have on neurocognitive functioning in individuals with cocaine use disorder.
    Mahoney JJ; Kalechstein AD; Newton TF; De La Garza R
    J Psychopharmacol; 2017 Aug; 31(8):989-995. PubMed ID: 28695777
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A closer look at depression and its relationship to HIV antiretroviral adherence.
    Wagner GJ; Goggin K; Remien RH; Rosen MI; Simoni J; Bangsberg DR; Liu H;
    Ann Behav Med; 2011 Dec; 42(3):352-60. PubMed ID: 21818528
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurocognitive characteristics of individuals with schizophrenia and cocaine dependence: comparison of currently dependent and remitted groups.
    Peer J; Bennett ME; Bellack AS
    J Nerv Ment Dis; 2009 Aug; 197(8):631-4. PubMed ID: 19684503
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Associations among correlates of schedule adherence to antiretroviral therapy (ART): a path analysis of a sample of crack cocaine using sexually active African-Americans with HIV infection.
    Atkinson JS; Schönnesson LN; Williams ML; Timpson SC
    AIDS Care; 2008 Feb; 20(2):253-62. PubMed ID: 18293137
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Depression and neurocognitive performance in Portuguese patients infected with HIV.
    Bragança M; Palha A
    AIDS Behav; 2011 Nov; 15(8):1879-87. PubMed ID: 21598031
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The relationship between neuropsychological functioning and HAART adherence in HIV-positive adults: a systematic review.
    Lovejoy TI; Suhr JA
    J Behav Med; 2009 Oct; 32(5):389-405. PubMed ID: 19291386
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neurocognitive impairment among HIV-positive individuals in Botswana: a pilot study.
    Lawler K; Mosepele M; Ratcliffe S; Seloilwe E; Steele K; Nthobatsang R; Steenhoff A
    J Int AIDS Soc; 2010 Apr; 13():15. PubMed ID: 20406460
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The impact of neuropsychological functioning on adherence to HAART in HIV-infected substance abuse patients.
    Applebaum AJ; Reilly LC; Gonzalez JS; Richardson MA; Leveroni CL; Safren SA
    AIDS Patient Care STDS; 2009 Jun; 23(6):455-62. PubMed ID: 19519229
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of cognitive functioning on treatment attendance and adherence in comorbid bipolar disorder and cocaine dependence.
    Fagan CS; Carmody TJ; McClintock SM; Suris A; Nakamura A; Jeon-Slaughter H; Lo A; Brown ES
    J Subst Abuse Treat; 2015 Feb; 49():15-20. PubMed ID: 25108685
    [TBL] [Abstract][Full Text] [Related]  

  • 36. "We fear the police, and the police fear us": structural and individual barriers and facilitators to HIV medication adherence among injection drug users in Kiev, Ukraine.
    Mimiaga MJ; Safren SA; Dvoryak S; Reisner SL; Needle R; Woody G
    AIDS Care; 2010 Nov; 22(11):1305-13. PubMed ID: 20640954
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of Human Immunodeficiency Virus Infection and Former Cocaine Dependence on Neuroanatomical Measures and Neurocognitive Performance.
    Wakim KM; Freedman EG; Tivarus ME; Christensen Z; Molholm S; Foxe JJ
    Neuroscience; 2022 Oct; 502():77-90. PubMed ID: 35963584
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Depressive symptoms, neurocognitive impairment, and adherence to highly active antiretroviral therapy among HIV-infected persons.
    Ammassari A; Antinori A; Aloisi MS; Trotta MP; Murri R; Bartoli L; Monforte AD; Wu AW; Starace F
    Psychosomatics; 2004; 45(5):394-402. PubMed ID: 15345784
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictors and Impact of Self-Reported Suboptimal Effort on Estimates of Prevalence of HIV-Associated Neurocognitive Disorders.
    Levine AJ; Martin E; Sacktor N; Munro C; Becker J;
    J Acquir Immune Defic Syndr; 2017 Jun; 75(2):203-210. PubMed ID: 28328547
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factors associated with optimal pharmacy refill adherence for antiretroviral medications and plasma HIV RNA non-detectability among HIV-positive crack cocaine users: a prospective cohort study.
    Hayashi K; Wood E; Kerr T; Dong H; Nguyen P; Puskas CM; Guillemi S; Montaner JS; Milloy MJ
    BMC Infect Dis; 2016 Aug; 16(1):455. PubMed ID: 27568002
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.